Hypercalcemia associated with malignancy in a horse.

The research study discusses a case of a malignancy-related hypercalcemia in a two-year-old Thoroughbred filly horse that had been experiencing weight loss and reduced exercise tolerance.

Summary of the Case

• The horse had been admitted to the clinic due to a present condition of weight loss and a reduction in its exercise tolerance which had lasted for about two months.
• During the clinical investigations, several medical conditions were discovered. These included hypercalcemia (high calcium levels in the blood), hypophosphatemia (low phosphate levels in the blood), anemia (lower than normal number of red blood cells), and a considerable neutrophilia (high number of white blood cells known as neutrophils), coupled with lymphopenia and eosinopenia (lower than normal number of lymphocytes and eosinophils, respectively).
• An immunoreactive parathyroid hormone concentration test indicated normal values.

Necropsy Findings

• Upon carrying out the necropsy, a substantial tumor weighing approximately 53.6 kilograms was discovered in the area of the horse’s abdominal cavity. Gross renal lesions, however, were not spotted.
• Both the bone tissue and the parathyroid glands seemed to be normal according to the gross and histologic examinations. Hypercalcemia (high calcium levels), renal phosphate excretion in the presence of hypophosphatemia (low phosphate levels), and absence of bone metastases are suggestive signs of a malignancy.

Diagnosis Process

• There isn’t an exclusive test for determining the presence of malignancy-associated hypercalcemia. It was diagnosed based on the clinical history, physical examination of the horse, interpretation of the radiography results, laboratory findings, and histologic examinations.
• Additionally, ruling out other potential causes of hypercalcemia was a critical aspect of the diagnostic process.
• When an abdominal mesenchymal tumor was identified that could have stemmed from the left ovary, and in correlation with the presence of hypercalcemia and hypophosphatemia, and absence of bone metastases, this fulfilled the fundamental criteria for a cancer-originated hypercalcemia diagnosis.